Diagnostic value of prostate specific antigen and its density in Iranian men with prostate cancer

Iranian Red Crescent Medical Journal

Volumn 11, Issue 2, 2009, Pages 170-175

  Lotfi, Mehrzad ^a   Assadsangabi, R ^a   Shirazi, M ^a   Jali, R ^a   Assadsangabi, A ^a   Nabavizadeh, S A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Density; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRAN; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 67649403363     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151(5) :1283-90. [7512659]
2. Littrup PJ, Sparschu R. Transrectal ultrasound and prostate cancer risks. Cancer 1995;755:1805-13. [doi:10.1002/ 1097-0142(19950401) 75:7+<1805::AID-CNCR282075160 9>3.0.CO;2-K]
3. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147:817-21. [1371555]
4. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N. Prostate specific antigen in the diagnosis and treatment of adeno-carcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989;141:1076-83. [2468795]
5. Narayan P, Ashutosh, Badrinath K. Prostate cancer: Part I. Diagnosis and staging. Hospital Physician 1996;34:10-24.
6. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update. JAMA 1997; 277:1445-51. [9145716] [doi:10.10 01/jama.277.18.1445]
7. Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR. Populationbased screening for prostate cancer by measuring total serum prostate-specific antigen in Iran. Int J Urol 2007;14:406-11. [17511722] [doi:10.1111/ j.1442-2042.2006.01729.x]
8. Mehrabi S, Ghafarian Shirazi HR, Rasti M, Bayat B. Analysis of serum prostate-specific antigen levels in men aged 40 years and older in yasuj, iran. Urol J 2005;2:189-92. [17602427]
9. Abdalla I, Ray P, Vaida F, Vijayakumar S. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer. Am J Clin Oncol 1999; 22:537-41. [10597 735] [doi:10.1097/00000421-19991 2000-00001]
10. Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 1993;150:369-73. [7686982]
11. Gregorio EP, Grando JP, Saqueti EE, Almeida SH, Moreira HA, Rodrigues MA. Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/mL. Int Braz J Urol 2007;33:151-60. [17488533] [doi:10.1590/S1677-55382007000200004]
12. Bazinet M, Meshref AW, Trudel C, Aronson S, Péloquin F, Nachabe M, Bégin LR, Elhilali MM. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 1994;43:44-51. [7506853] [doi:10.1016/ S0090-4295(94)80260-2]
13. Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2031-6. [7525994]
14. Cookson MS, Floyd MK, Ball TP Jr, Miller EK, Sarosdy MF. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol 1995; 154:1070-3. [7543601] [doi:10.1016/S0022-5347 (01)66979-9]
15. Okegawa T, Noda H, Nutahara K, Higashihara E. Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL. Urology 2000;55:700-4. [10792084] [doi:10.1016 /S0090-4295(99)00589-0]